Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.73 USD
Change Today -0.0081 / -1.10%
Volume 41.8K
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

implant sciences corp (IMSC) Snapshot

Open
$0.73
Previous Close
$0.74
Day High
$0.73
Day Low
$0.70
52 Week High
09/11/14 - $1.82
52 Week Low
05/29/15 - $0.64
Market Cap
54.3M
Average Volume 10 Days
82.2K
EPS TTM
$-0.34
Shares Outstanding
74.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMPLANT SCIENCES CORP (IMSC)

Related News

No related news articles were found.

implant sciences corp (IMSC) Related Businessweek News

No Related Businessweek News Found

implant sciences corp (IMSC) Details

Implant Sciences Corporation, together with its subsidiaries, develops, manufactures, and sells sensors and systems for the security, safety, and defense industries primarily in the United States and internationally. Its products include Quantum Sniffer QS-H150 portable explosives detector for the simultaneous detection of explosives particulates and vapors with or without physical contact and in real-time; and Quantum Sniffer QS-B220 desktop explosives and narcotics detector for the detection and identification of various military, commercial, and improvised explosives, as well as narcotics. Implant Sciences offers its products for use in aviation and transportation security, high threat facilities and infrastructure, military installations, customs and border protection, and mail and cargo screening. The company markets and sells its products through direct sales and marketing staff, as well as through a network of independent and specialized sales representatives, and distributors. Implant Sciences Corporation was founded in 1984 and is headquartered in Wilmington, Massachusetts.

74 Employees
Last Reported Date: 09/29/14
Founded in 1984

implant sciences corp (IMSC) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $270.0K
Chief Financial Officer and Vice President of...
Total Annual Compensation: $230.0K
Vice President of Technology & Product Develo...
Total Annual Compensation: $200.0K
Vice President, Sales, Marketing and Technica...
Total Annual Compensation: $245.0K
Compensation as of Fiscal Year 2014.

implant sciences corp (IMSC) Key Developments

Implant Sciences Corporation Announces Appointment of Robert Liscouski as President

Implant Sciences Corporation announced the appointment of Robert Liscouski to the position of President. Mr. Liscouski, formerly Executive Vice President, will continue to serve on the company's Board of Directors. Dr. Bill McGann will continue to serve as Implant Sciences' CEO and as a member of the company's Board of Directors. Mr. Liscouski is a recognized international security and counterterrorism expert with more than 30 years of experience as a senior government official, business leader, entrepreneur, special agent and law enforcement officer. He has been Executive Vice President of Implant Sciences since February, 2015, and has served on the Implant Sciences Board of Directors since 2009. In 2003, he was appointed by President George W. Bush as the first Assistant Secretary for Infrastructure Protection at the U.S. Department of Homeland Security. There he worked closely with the White House and other federal agencies to design, develop and implement the framework to protect the nation's critical physical and cyber infrastructure following 9/11. Later Mr. Liscouski founded a strategic advisory firm specializing in technology start-ups in the homeland security area. Early in his career, Mr. Liscouski worked in local law enforcement as a homicide and undercover investigator and special agent for the Diplomatic Security Service before joining a Fortune 100 company to develop security systems to protect information technology and intellectual property.

Implant Sciences Corporation Receives Order from International Airports in Austria

Implant Sciences Corporation announced that it has sold 22 of its QS-B220 desktop trace detectors to international airports in Austria, continuing its sales success in the European aviation market. With this contract win, international airports in 11 EU countries have selected Implant Sciences' QS-B220 since late April 2015, with orders totaling up to 883 units to such airports.

Implant Sciences Wins 50 Unit German Airport Order

Implant Sciences Corporation announced an important sale of 50 of its QS-B220 desktop explosives trace detectors to several international airports in Germany.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMSC:US $0.73 USD -0.0081

IMSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bruker Corp $17.81 USD -0.19
CR Bard Inc $187.93 USD -2.46
Safran SA €66.64 EUR -1.65
Thermo Fisher Scientific Inc $121.17 USD -1.60
View Industry Companies
 

Industry Analysis

IMSC

Industry Average

Valuation IMSC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPLANT SCIENCES CORP, please visit www.implantsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.